Susquehanna International Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-88,499
| Closed | -$319K | – | 10811 |
|
|
2018
Q2 | $333K | Buy |
+88,499
| New | +$431K | ﹤0.01% | 7643 |
|
|
2018
Q1 | – | Sell |
-153,785
| Closed | -$716K | – | 10715 |
|
|
2017
Q4 | $715K | Sell |
153,785
-119,121
| -44% | -$656K | ﹤0.01% | 5907 |
|
|
2017
Q3 | $1.94M | Buy |
272,906
+37,198
| +16% | +$267K | ﹤0.01% | 3974 |
|
|
2017
Q2 | $1.7M | Buy |
235,708
+205,833
| +689% | +$1.29M | ﹤0.01% | 4209 |
|
|
2017
Q1 | $184K | Sell |
29,875
-468,981
| -94% | -$2.57M | ﹤0.01% | 8071 |
|
|
2016
Q4 | $2.92M | Buy |
498,856
+162,734
| +48% | +$889K | ﹤0.01% | 3295 |
|
|
2016
Q3 | $1.78M | Sell |
336,122
-31,745
| -9% | -$171K | ﹤0.01% | 3750 |
|
|
2016
Q2 | $2.44M | Sell |
367,867
-320,085
| -47% | -$1.79M | ﹤0.01% | 3250 |
|
|
2016
Q1 | $3.21M | Buy |
687,952
+306,759
| +80% | +$1.22M | ﹤0.01% | 2957 |
|
|
2015
Q4 | $1.93M | Buy |
381,193
+235,311
| +161% | +$1.12M | ﹤0.01% | 4114 |
|
|
2015
Q3 | $514K | Buy |
145,882
+116,030
| +389% | +$777K | ﹤0.01% | 7070 |
|
|
2015
Q2 | $298K | Sell |
29,852
-339,418
| -92% | -$3.64M | ﹤0.01% | 8547 |
|
|
2015
Q1 | $4.7M | Buy |
369,270
+227,722
| +161% | +$2.93M | ﹤0.01% | 2826 |
|
|
2014
Q4 | $2M | Buy |
141,548
+44,717
| +46% | +$693K | ﹤0.01% | 4465 |
|
|
2014
Q3 | $1.33M | Sell |
96,831
-11,457
| -11% | -$175K | ﹤0.01% | 5362 |
|
|
2014
Q2 | $1.67M | Buy |
108,288
+79,378
| +275% | +$1.13M | ﹤0.01% | 5012 |
|
|
2014
Q1 | $493K | Sell |
28,910
-868,170
| -97% | -$13.1M | ﹤0.01% | 6759 |
|
|
2013
Q4 | $11.6M | Buy |
897,080
+561,593
| +167% | +$6.71M | 0.01% | 1886 |
|
|
2013
Q3 | $3.39M | Buy |
335,487
+137,877
| +70% | +$1.23M | ﹤0.01% | 3295 |
|
|
2013
Q2 | $1.48M | Buy |
+197,610
| New | +$1.54M | ﹤0.01% | 4380 |
|
Susquehanna International Group's KERX Position: Q3 2018 in Review
Susquehanna International Group sold out of Keryx Biopharmaceuticals Inc (KERX) in Q3 2018, closing a stake of 88,499 shares — an estimated $319K sold.
Susquehanna International Group first reported a position in KERX in Q2 2013 and held it in 20 quarters. The position peaked at $11.6M in Q4 2013. 123 funds tracked by Wall St. Rank hold KERX as of Q3 2018.
- Susquehanna International Group reported no remaining Keryx Biopharmaceuticals Inc position as of Q3 2018 after selling out during the quarter.
- Susquehanna International Group sold 88,499 Keryx Biopharmaceuticals Inc shares in Q3 2018, an estimated $319K.
- Susquehanna International Group first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 20 quarters.
- Susquehanna International Group's Keryx Biopharmaceuticals Inc position peaked at $11.6M in Q4 2013.
- 123 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q3 2018.
Based on Susquehanna International Group's 13F filing for Q3 2018, filed 14 Nov 2018.